Product Information
PHENOBARBITAL 32.4 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0828 per EA under NDC 00904657580. Its NADAC has been published 267 times since Apr 21, 2021.
Strength
32.4 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904657580
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
2/1/2003
Price Statistics
The NADAC for PHENOBARBITAL 32.4 MG TABLET has been published 267 times since Apr 21, 2021, and over the history we have for it it has declined 76.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0828 per EA |
|---|---|
| All-time high | $0.3526 (May 12, 2021) |
| All-time low | $0.0828 (May 20, 2026) |
| 52-week high | $0.1625 |
| 52-week low | $0.0828 |
| Median price | $0.1657 |
| Average price | $0.1930 |
| Largest weekly change | +62.6% (Jun 19, 2024) |
| Weeks tracked | 267 |
| Tracking since | Apr 21, 2021 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 32.4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 32.4 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0828 per EA (NDC 00904657580), effective May 27, 2026.
How has the price of PHENOBARBITAL 32.4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 32.4 MG TABLET has declined 76.5%. It has been tracked across 267 weekly CMS publications since Apr 21, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 32.4 MG TABLET?
Since Apr 21, 2021, the NADAC for PHENOBARBITAL 32.4 MG TABLET has ranged from a low of $0.0828 (May 20, 2026) to a high of $0.3526 (May 12, 2021), with a median of $0.1657 per EA.
Are there cheaper alternatives to PHENOBARBITAL 32.4 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENOBARBITAL 32.4 MG TABLET, is $0.0757 per EA — about 9% below PHENOBARBITAL 32.4 MG TABLET.
Who manufactures PHENOBARBITAL 32.4 MG TABLET?
PHENOBARBITAL 32.4 MG TABLET (NDC 00904657580) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification